PTC Therapeutics ALS drug fails to meet endpoints as trials shut down

PTC Therapeutics ALS drug fails to meet endpoints as trials shut down

Submitted by admin on November 27, 2024 - 11:40am
Source: 
Clinical Trials Arena
News Tags: 
PTC Therapeutics
ALS
clinical trials
utreloxastat
Headline: 
PTC Therapeutics ALS drug fails to meet endpoints as trials shut down
snippet: 

The announcement means the company will be pulling the plug on the CardinALS trial after its amyotrophic lateral sclerosis drug failed to halt disease progression.

Do Not Allow Advertisers to Use My Personal information